R
Richard Bucala
Researcher at Yale University
Publications - 622
Citations - 58697
Richard Bucala is an academic researcher from Yale University. The author has contributed to research in topics: Macrophage migration inhibitory factor & Cytokine. The author has an hindex of 119, co-authored 595 publications receiving 54607 citations. Previous affiliations of Richard Bucala include École Polytechnique Fédérale de Lausanne & Rockefeller University.
Papers
More filters
Journal ArticleDOI
MIF (Macrophage Migration Inhibitory Factor) Promoter Polymorphisms and Susceptibility to Severe Malarial Anemia
Gordon A. Awandare,Jeremy J. Martinson,Tom Were,Collins Ouma,Collins Ouma,Gregory C. Davenport,John M. Ong’echa,Wen Kui Wang,Lin Leng,Robert E. Ferrell,Richard Bucala,Douglas J. Perkins,Douglas J. Perkins +12 more
TL;DR: The findings demonstrate that variation in the MIF promoter influences susceptibility to SMA and peripheral MIF production, however, the Mif -173 and -794 polymorphisms appear to have both independent and interactive effects on different measures of disease severity, suggesting that MIF plays a complex role in malarial pathogenesis.
Journal ArticleDOI
Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling.
Sho-ichi Yamagishi,Riichiro Abe,Yosuke Inagaki,Kazuo Nakamura,Hiroshi Sugawara,Daisuke Inokuma,Hideki Nakamura,Tadamichi Shimizu,Masayoshi Takeuchi,Akihiko Yoshimura,Richard Bucala,Hiroshi Shimizu,Tsutomu Imaizumi +12 more
TL;DR: It is found that minodronate inhibited melanoma growth and improved survival in nude mice by suppressing the tumor-associated angiogenesis and macrophage infiltration and suppressing the VEGF signaling.
Journal ArticleDOI
Expression of Inducible 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase/PFKFB3 Isoforms in Adipocytes and Their Potential Role in Glycolytic Regulation
Toshiya Atsumi,Taro Nishio,Hirokatsu Niwa,Jun Takeuchi,Hidenori Bando,Chikara Shimizu,Narihito Yoshioka,Richard Bucala,Takao Koike +8 more
TL;DR: Anti-phospho-iPFK-2(Ser461) Western blotting revealed strong reactivity in insulin-treated 3T3-L1 adipocyte, suggesting that insulin induces the phosphorylation of PFKFB3 protein, expanding the role of these structurally unique iPFK- 2/PFKFB 3 isoforms in the metabolic regulation of adipocytes.
Journal ArticleDOI
A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria
Tiffany Sun,Thomas Holowka,Yan Song,Swen Zierow,Lin Leng,Yibang Chen,Huabao Xiong,Jason W. Griffith,Mehdi Nouraie,Philip E. Thuma,Elias Lolis,Chris J. Janse,Victor R. Gordeuk,Kevin D. Augustijn,Richard Bucala +14 more
TL;DR: It is observed that the Plasmodium ortholog of macrophage migration inhibitory factor enhanced inflammatory cytokine production and also induced antigen-experienced CD4 T cells to develop into short-lived effector cells rather than memory precursor cells, indicating that PlasModia actively interfere with the development of immunological memory.
Journal ArticleDOI
MIF and D-DT are potential disease severity modifiers in male MS subjects
Gil Benedek,Roberto Meza-Romero,Kelley Jordan,Ying Zhang,Ha Nguyen,Gail Kent,Jia Li,Edwin Siu,Jenny Frazer,Marta Piecychna,Xin Du,Antoine G. Sreih,Lin Leng,Jack Wiedrick,Stacy J. Caillier,Halina Offner,Jorge R. Oksenberg,Vijayshree Yadav,Dennis Bourdette,Richard Bucala,Arthur A. Vandenbark +20 more
TL;DR: It is demonstrated that genetically controlled high MIF expression (and D-DT) promotes MS progression in males, suggesting that these two factors are sex-specific disease modifiers and raising the possibility that aggressive anti-MIF treatment of clinically isolated syndrome or RRMS males with a high-expresser genotype might slow or prevent the onset of progressive MS.